Beyond the FDA: Monitoring Global Medical Device Regulators

The blind spots in FDA-only monitoring

Three structural reasons make single-regulator monitoring incomplete:

• Signals are jurisdiction-first. A field safety corrective action often appears with one regulator before the others — a competitor's recall in Canada, or an MHRA field safety notice, can be your earliest warning about a component or device class you share.
• The publications don't overlap cleanly. Each regulator has its own document types — MAUDE-style adverse-event feeds, field safety notices, national recall registries, rapid-alert systems. None of them republishes the others.
• Your obligations are multi-jurisdiction too. If you hold a UKCA/CE marking or sell into Canada or Switzerland, your post-market surveillance plan is expected to cover signals in those markets — an EU MDR PMS plan that only cites US data is a gap an auditor can find. (See our guide to EU MDR Articles 83–92.)

openFDA (United States)

The US remains the deepest public source: adverse events (MAUDE), recalls and enforcement reports, 510(k)/PMA clearances, and the GUDID device registry — much of it accessible programmatically through the openFDA APIs. It's the backbone of any monitoring programme; our separate guide covers how to monitor FDA MAUDE in depth. The point of this article is what it doesn't cover: everything below.

MHRA (United Kingdom)

The Medicines and Healthcare products Regulatory Agency publishes device safety information and field safety notices — the manufacturer-issued notices that accompany field safety corrective actions in the UK — alongside device alerts and recall information. Post-Brexit, the UK runs its own regulatory track, so UK signals no longer arrive bundled with EU ones. If you hold UKCA marking or sell through UK distributors, MHRA publications are a primary source, not a duplicate of EU data.

Health Canada

Health Canada maintains a national recalls and safety alerts database covering medical devices, and publishes medical device incident data. Canadian recalls frequently include devices and lots that differ from the equivalent US action — and sometimes precede it. For manufacturers with Canadian licences, monitoring here is also a direct input to mandatory problem-reporting obligations.

EU Safety Gate

Safety Gate is the EU's rapid alert system for dangerous non-food products. It's broader than medical devices, but device-related alerts appear there — often for products sold to consumers through channels that bypass normal medical distribution. That makes it a useful complement to formal device vigilance: it catches the consumer-channel edge of the market where grey-market and non-compliant devices tend to show up first.

Swissmedic

Switzerland sits outside the EU regulatory system, and since the lapse of the EU-Swiss mutual recognition agreement for medical devices, it has operated its own regime. Swissmedic publishes recalls and field safety corrective actions affecting the Swiss market. For manufacturers selling into Switzerland, these publications are the authoritative national record — and another early-warning channel for actions that later propagate to other jurisdictions.

EUDAMED

EUDAMED is the EU's central medical-device database under the MDR, spanning actor registration, UDI/device registration, certificates, vigilance and market surveillance. It is rolling out in phases, with modules becoming available — and mandatory — over time. Even in its current partial state, its public data is worth watching: device and certificate registrations are visible, and as the vigilance module matures it will become a primary EU-wide signal source. Building it into your monitoring now means you're not retrofitting later.

Consolidating six sources into one view

The problem with all of the above isn't access — every source is public. It's that they're six different websites, six formats, six search interfaces and six update rhythms. Checking them by hand for every device in your portfolio doesn't survive contact with a real product catalogue, which is why most teams quietly fall back to FDA-only.

The consolidation pattern that works:

• Ingest continuously from all six sources into one store, so lookups run against current data instead of six live websites.
• Normalise around the device — one search for a device or model should return every jurisdiction's notices side by side.
• Alert on change — a new notice matching your watchlist should reach you by notification, not by someone remembering to check.
• Keep the evidence — every finding logged and preserved, so the same data that alerts you also feeds your PMS report or PSUR with a defensible trail.